2985, cedar Brook drive

Decatur GA 30033

Global Nuclear Medicine & Radio Pharmaceuticals Market 2020 and Forecast 2029

Global Nuclear Medicine & Radio Pharmaceuticals Market 2020 and Forecast 2029

Published Date : 01-June-2020 | Pages : 200+ | Included Covid – 19 Impacted Analysis

Description

We, at CRR, have always studied the market in-depth and have been doing the pressure testing since our inception. Given the current pandemic situation, we all are of consensus that it is a constant now. Owing to which, the report addresses COVID-19 effects on this market too.

Key Companies :
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group
Ltd

Market by Type :
Diagnostic Medicine: SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters
Alpha Emitters
Brachytherapy Isotopes

Market by Application :
Diagnostic Applications: SPECT
PET.
Therapeutic Applications: Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors and Other Therapeutic Applications.

By Region :
Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

In this study, the years considered to estimate the market size of report are as follows:
History Year: 2013-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2029
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Additional information

Select License

,

TOC

Chapter 1 Global Nuclear Medicine & Radio Pharmaceuticals Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Nuclear Medicine & Radio Pharmaceuticals Market
1.4 Restraints for Nuclear Medicine & Radio Pharmaceuticals Market
1.5 Opportunities for Nuclear Medicine & Radio Pharmaceuticals Market
1.6 Trends for Nuclear Medicine & Radio Pharmaceuticals Market
1.7 COVID-19 Impact Assessment on Nuclear Medicine & Radio Pharmaceuticals Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Nuclear Medicine & Radio Pharmaceuticals Market Overview
2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market by Product Type
2.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Nuclear Medicine & Radio Pharmaceuticals Market by End User
2.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Nuclear Medicine & Radio Pharmaceuticals Market by Region
2.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Nuclear Medicine & Radio Pharmaceuticals Market Outlook (2013-2029)
2.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Region
2.8.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by End User
2.9 Global Nuclear Medicine & Radio Pharmaceuticals Market Share Comparison (2013-2029)
2.9.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Region
2.9.2 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by Product Type
2.9.3 Global Nuclear Medicine & Radio Pharmaceuticals Market Share by End User

Chapter 3 North America Nuclear Medicine & Radio Pharmaceuticals Market Overview
3.1 North America Nuclear Medicine & Radio Pharmaceuticals Market by Product Type
3.1.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Nuclear Medicine & Radio Pharmaceuticals Market by End User
3.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Nuclear Medicine & Radio Pharmaceuticals Market by Region
3.3.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Nuclear Medicine & Radio Pharmaceuticals Market Outlook (2013-2029)
3.4.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Region
3.8.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by End User
3.9 North America Nuclear Medicine & Radio Pharmaceuticals Market Share Comparison (2013-2029)
3.9.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Share by Region
3.9.2 North America Nuclear Medicine & Radio Pharmaceuticals Market Share by Product Type
3.9.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Share by End User

Chapter 4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Overview
4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market by Product Type
4.1.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market by End User
4.2.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market by Region
4.3.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Outlook (2013-2029)
4.4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Region
4.8.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by End User
4.9 Europe Nuclear Medicine & Radio Pharmaceuticals Market Share Comparison (2013-2029)
4.9.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Region
4.9.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by Product Type
4.9.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Share by End User

Chapter 5 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Overview
5.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market by Product Type
5.1.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market by End User
5.2.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market by Region
5.3.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Outlook (2013-2029)
5.4.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Share by Region
5.9.2 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Share by Product Type
5.9.3 Asia Pacific Nuclear Medicine & Radio Pharmaceuticals Market Share by End User

Chapter 6 South America Nuclear Medicine & Radio Pharmaceuticals Market Overview
6.1 South America Nuclear Medicine & Radio Pharmaceuticals Market by Product Type
6.1.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Nuclear Medicine & Radio Pharmaceuticals Market by End User
6.2.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Nuclear Medicine & Radio Pharmaceuticals Market by Region
6.3.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Nuclear Medicine & Radio Pharmaceuticals Market Outlook (2013-2029)
6.4.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Region
6.8.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by End User
6.9 South America Nuclear Medicine & Radio Pharmaceuticals Market Share Comparison 2013-2029
6.9.1 South America Nuclear Medicine & Radio Pharmaceuticals Market Share by Region
6.9.2 South America Nuclear Medicine & Radio Pharmaceuticals Market Share by Product Type
6.9.3 South America Nuclear Medicine & Radio Pharmaceuticals Market Share by End User

Chapter 7 MEA Nuclear Medicine & Radio Pharmaceuticals Market Overview
7.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market by Product Type
7.1.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market by End User
7.2.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Nuclear Medicine & Radio Pharmaceuticals Market by Region
7.3.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Nuclear Medicine & Radio Pharmaceuticals Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Nuclear Medicine & Radio Pharmaceuticals Market Outlook (2013-2029)
7.4.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Region
7.8.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Nuclear Medicine & Radio Pharmaceuticals Market Y-o-Y Growth Rate by End User
7.9 MEA Nuclear Medicine & Radio Pharmaceuticals Market Share Comparison (2013-2029)
7.9.1 MEA Nuclear Medicine & Radio Pharmaceuticals Market Share by Region
7.9.2 MEA Nuclear Medicine & Radio Pharmaceuticals Market Share by Product Type
7.9.3 MEA Nuclear Medicine & Radio Pharmaceuticals Market Share by End User

Chapter 8 Global Nuclear Medicine & Radio Pharmaceuticals Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis…
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group
Ltd

Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

$ 3900$ 7800

  • Corporate Price
  • Individual Price
Clear

For More Information

Email us at:

sales@credenceresearchreports.com

Call us at:

+1-925-478-7203